Position in PTGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$122
+$122 QoQ
Shares Held
1
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#341
of 341 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Derivatives in PTGX
reported options exposure · as of Jun 30, 2026CallValue
$539,352
CallShares
4,400
PutValue
$12,258
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. PTGX ranks #123 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in PTGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122 | 1 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $539,352 | 4,400 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $12,258 | 100 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $3,246,320 | 30,800 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $748,340 | 7,100 | Put | Sole | 2026-05-13 | |
| 2025-12-31 | $2,061,224 | 23,600 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $558,976 | 6,400 | Put | Sole | 2026-02-13 | |
| 2024-09-30 | $4,740,075 | 105,335 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $3,879,918 | 134,114 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,251,818 | 185,426 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,232,050 | 133,816 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $1,454,496 | 52,661 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $317,630 | 11,500 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $58,002 | 2,100 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $2,929,510 | 127,370 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $121,900 | 5,300 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $5,720,134 | 524,302 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $867,809 | 102,943 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,035,693 | 257,357 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $790,675 | 33,390 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $3,351,531 | 97,998 | Shares | Sole | 2022-05-27 | |
| 2021-09-30 | $179,255 | 10,116 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||